Tolaney Sara M, Winer Eric P
Dana Farber Cancer Institute, 44 Binney Street, Mayer 2, Boston, MA 02115, USA.
Breast. 2007 Dec;16 Suppl 2:S45-50. doi: 10.1016/j.breast.2007.07.005. Epub 2007 Aug 13.
In the US, over 200,000 new cases of invasive breast cancer are diagnosed each year, with an additional 60,000 cases of ductal carcinoma in situ. The majority of these women will never experience a recurrence of their disease, and most will survive more than 5 years. Follow-up care for these women is focused on addressing long-term complications of therapy, and early detection of new primary cancers and locoregional recurrences. There is no evidence that early detection of distant metastases will lead to an increase in survival, and currently routine imaging studies are not recommended. With the growing number of breast cancer survivors, further studies should be undertaken to study the cost-effectiveness of surveillance strategies.
在美国，每年有超过20万例浸润性乳腺癌新发病例，另有6万例导管原位癌病例。这些女性中的大多数不会经历疾病复发，并且大多数将存活超过5年。对这些女性的后续护理重点在于处理治疗的长期并发症，以及早期发现新的原发性癌症和局部区域复发。没有证据表明早期发现远处转移会提高生存率，目前不建议进行常规影像学检查。随着乳腺癌幸存者数量的增加，应进一步开展研究以探讨监测策略的成本效益。
